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FOOT pain is a common problem among community-dwelling older adults. The importance of foot pain to 
the individual and from a public health perspective relates 
to its frequent association with physical impairments, such 
as poor balance (1), risk of falling (2), and locomotor 
disability (1,3–11).
Estimates of the population prevalence of foot pain in 
older adults range from 18% to 42% (1,3,4,8,10). Foot pain is 
more prevalent in women than in men (4,7,8)], but the rela-
tionship with age is less clear, with reports of higher, lower, 
and unchanged prevalence in older people (4,7,8,10)]. There 
are fewer estimates of the population prevalence of disabling 
foot pain, but they vary between 8% and 22% (6,12).
These existing estimates are cross-sectional and provide 
one indication of the current burden of disabling foot pain. 
Prospective data about the natural history of disabling foot 
pain are lacking. Such data would provide estimates of fu-
ture burden and help to identify factors that could be tar-
geted to prevent onset of or aid recovery from the problem.
The objectives of this study were (i) to determine the on-
set and persistence of disabling foot pain over 3 years and 
how this relates to the prior presence of nondisabling foot 
pain and (ii) to examine the influence of age and gender on 
the onset and persistence of disabling foot pain.
Methods
The study design was a prospective cohort study (recruit-
ment and 3-year follow-up) of an older adult population 
using postal questionnaires. Both baseline and 3-year follow-
up surveys consisted of a two-stage process involving an 
initial health survey questionnaire and a subsequent more 
intensive regional pains survey questionnaire. Ethical approval 
for all stages was obtained from the North Staffordshire Local 
Research Ethics Committee. The health survey question-
naire included a consent form on which participants indi-
cated their consent for use of their health care data and for 
further postal contact.
Baseline Survey
The North Staffordshire Osteoarthritis Project (NorStOP) 
study protocol, data collection, and recruitment results have 
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been published previously (13,14). In summary, the sam-
pling frame at recruitment consisted of all adults aged 
50 years and older registered with three general practices 
from the North Staffordshire Primary Care Research Con-
sortium (n = 11,309). Practice registers were examined by 
the general practitioners for exclusions (eg, severe psychiat-
ric illness or terminal illness) prior to mailing.
In the first stage health survey questionnaire, participants 
were asked if they had experienced pain in and around the 
hands, hips, knees, or feet or problems in and around their 
hands in the last year. Those responding positively to any of 
these five screening questions and giving permission for 
recontact were mailed the second stage regional pain survey 
questionnaire. This repeated the screening question regard-
ing foot pain in the last year and included the Manchester 
Foot Pain and Disability Index (MFPDI) (15).
Three-Year Follow-Up Survey
The same two-stage mailing procedure was repeated at 
3-year follow-up in participants who had given written per-
mission at baseline for further contact. Practice registers 
were screened for exclusions as at baseline. The records of 
persons no longer registered with their original practice were 
traced via the National Health Service registration system to 
establish their current address or whether they had died.
Definitions of Disabling Foot Pain, Onset, and Persistence
Definition of any foot pain.—At recruitment and 3-year 
follow-up, people were defined as having any foot pain if 
they responded “yes” to the item regarding foot pain on 
both the health survey questionnaire and the regional pain 
survey questionnaire and as not having any foot pain if they 
responded “no” to this item on both questionnaires. Persons 
responding inconsistently in the two questionnaires, at ei-
ther baseline or 3-year follow-up, were excluded from the 
current analysis.
Definition of disabling foot pain.—The MFPDI is a 19-
item self-completed questionnaire that assesses foot pain–
related problems across four constructs: pain (5 items), 
function (10 items), appearance (2 items), and work and leisure 
(2 items) (15). All 19 items are prefixed by the phrase 
“Because of pain in my feet,” and the 10 function items 
include avoiding standing for a long time, difficulty walking 
(eg, avoiding walking long distances, not walking in a nor-
mal way, having to walk slowly, avoiding hard, or rough 
surfaces), having to catch the bus or use the car more often, 
and needing help with housework and/or shopping (15). For 
the purpose of this study, respondents were considered to 
have disabling foot pain if they reported any foot pain (see 
definition earlier) and responded “on most/every day(s)” to 
at least 1 of the 10 items contained within Garrow’s func-
tion construct (15,16). All other people with any foot pain 
who completed the 10 function items of the MFPDI were 
defined as having nondisabling foot pain. This method has 
been shown to be valid and repeatable and to provide a 
meaningful differentiation between disabling and nondis-
abling foot pain (16). People with any foot pain who did not 
complete all 10 function items of the MFPDI were excluded.
Definition of onset and persistence of disabling foot pain.—
Onset of disabling foot pain was defined as the absence 
of disabling foot pain in the baseline survey and the pres-
ence of disabling foot pain in the 3-year follow-up survey. 
Persistent disabling foot pain was defined as disabling foot 
pain present in both baseline and 3-year follow-up surveys.
Statistical Analysis
All included respondents were placed into two groups at 
baseline and follow-up: any foot pain and no foot pain. 
Those with any foot pain were separated into two sub
groups: nondisabling and disabling foot pain.
In order to assess the impact of response bias at 3 years, 
age, gender, and baseline foot pain status were compared 
between three groups at 3 years: 3-year responders with 
complete foot pain data at both timepoints, 3-year re-
sponders with incomplete foot pain data at either/both time
point(s), and those lost to follow-up.
Onset of disabling foot pain at 3-year follow-up was cal-
culated as a percentage of the people who were without dis-
abling foot pain at baseline, overall and then by gender and 
age group. These latter figures were then broken down, 
overall and by gender and age group, into (i) those people 
who were without any foot pain at baseline and (ii) those 
people who had nondisabling foot pain at baseline. Among 
those people who reported onset of disabling foot pain at 
3-year follow-up, disabling foot pain onset was further 
categorized by the number of MFPDI function items on 
which people reported problems (1 only, 2–4, 5–7, and 8–10). 
The frequency with which each MFPDI function item 
was reported as occurring on most/every day(s) at 3-year 
follow-up was also calculated as a percentage of all those 
experiencing onset of disabling foot pain.
The persistence of any foot pain and disabling foot pain 
at the 3-year follow-up was calculated as a percentage of the 
people who were in the corresponding subgroup at baseline, 
overall and by gender and age group.
Percentage differences (95% confidence interval)were 
used to assess differences between gender groups, and chi-
square tests for linear trend were used to assess the differ-
ences across age groups.
Results
Response to Baseline and 3-Year Follow-Up Surveys
Of the 11,309 people sent the baseline health survey ques-
tionnaire, 7,878 responded (adjusted response: 71.3%) (14). 
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Following checks with the general practice for deaths, de-
partures, and serious illness in the follow-up period, 5,001 
people remained eligible and consented to be followed up 
at 3 years, 4,234 of whom responded (adjusted response 
84.7%) (17). After excluding those people who gave contra-
dictory responses to the foot pain question on the health sur-
vey and regional pains survey questionnaires, there were 
2,718 persons with data at both timepoints for the analysis of 
onset and persistence of foot pain over 3 years (Figure 1).
Baseline Differences Between 3-Year Responders With 
Complete Foot Pain Data, Incomplete Foot Pain Data, and 
Those Lost to Follow-Up
Responders at 3 years with complete foot pain data at both 
timepoints (n = 2,718) were younger than those with incom-
plete foot pain data at either/both timepoint(s) (n = 1,516) 
and those lost to 3-year follow-up (n = 3,644) (Table 1). 
There were no gender differences between the three groups. 
The proportion with disabling foot pain at baseline was 
greater in both 3-year responders with complete foot pain 
data at both timepoints and 3-year responders with incom-
plete foot pain data at both/either timepoints than in those 
lost to 3-year follow-up (16.9%, 34.4%, and 7.6%, respec-
tively), although baseline foot pain data were frequently 
incomplete in these two latter groups.
Onset of Disabling Foot Pain Over 3 Years
Of 2,718 persons with complete data at both timepoints, 
779 (28.7%) reported any foot pain at baseline, and 460 of 
these (16.9% of the study population) had disabling foot 
pain at baseline.
Of 2,258 people without disabling foot pain at baseline, 
184 (8.1%) had developed the problem by 3-year follow-up 
(Table 2). Of these, problems were reported on only 1 
MFPDI function item by 66 (35.9%), on 2–4 items by 
69 (37.5%), on 5–7 items by 33 (17.9%), and on 8–10 items 
by 16 (8.7%). The frequency with which each MFPDI func-
tion item was reported as occurring on most/every day(s) at 
3-year follow-up among those reporting onset of disabling 
foot pain is shown in Table 3. The onset of disabling foot 
pain was significantly greater in those with nondisabling foot 
pain at baseline than in persons without any foot pain (% dif-
ference: 14.2% [95% confidence interval: 10.0%–19.1%]) 
and in females compared with males (% difference: 2.5% 
Mailed baseline Health Survey n = 11309 
Respondents to baseline Health Survey 
n = 7878 (adjusted response rate 71.3%) 
Baseline Health Survey respondents providing 
complete foot pain data at baseline n = 5764
Mailed 3-year Health Survey n=4074 
Respondents to 3-year Health Survey 
n = 3471 (adjusted response 86.0%) 
Non-response/ineligible n = 3431 
Incomplete/inconsistent foot pain data at 
baseline n = 2114 
Baseline Health Survey respondents providing 
consent for further contact n = 4293
No permission for further contact n = 1471 
Deaths and exclusions prior to mailing 
n = 219 
Excluded during mailing n = 40 
Eligible 3-year population n = 4034 
Non-response n = 563 
3-year Health Survey respondents providing 
complete foot pain data at both time-points 
n = 2718
Incomplete/inconsistent foot pain data at 3-
year follow-up n = 753 
Figure 1. Flow diagram showing study participants.
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[95% confidence interval: 0.3%–4.8%]). Overall, the onset 
of disabling foot pain was higher at older ages. When consid-
ering this trend within each gender, it was true only for 
females. The age-related trend was especially marked in 
those with nondisabling foot pain at baseline, and there was 
no significant trend in the onset of disabling foot pain in 
those with no foot pain at baseline.
Foot Pain Persistence Over 3 Years
The persistence of foot pain, both any foot pain and dis-
abling foot pain, was high (73.9% and 71.7%, respectively) 
and significantly more likely in females than in males (Table 4). 
There were no significant age-related trends in relation to 
persistence in either foot pain group, overall or by gender.
Discussion
In this population of older people, onset of disabling foot 
pain at 3 years was reported by 8.1% of people who did not 
have disabling foot pain at baseline. Onset of disability 
related to foot pain was most frequently associated with need-
ing to rely upon vehicular transport more often, difficulty 
walking (such as walking slowly, avoiding adverse terrain, or 
Table 1. Baseline Characteristics of 3-Year Responders (stratified according to completeness of foot pain data) and Those Lost to Follow-Up at 
3 Years
Responders at 3 y
Lost to 3 y Follow-Up  
(n = 3,644), No (%)
Foot Pain Data Complete at Both  
Timepoints (n = 2,718), No (%)
Foot Pain Data Incomplete at Either/Both  
Timepoints (n = 1,516), No (%)
Age (y)
 50–59 1115 (41.0) 451 (29.7) 955 (26.2)
 60–69 905 (33.3) 508 (33.5) 939 (25.8)
 70+ 698 (25.7) 557 (36.7) 1750 (48.0)
Gender
 Female 1452 (53.4) 898 (59.2) 2066 (56.7)
 Male 1266 (46.6) 618 (40.8) 1578 (43.3)
Baseline foot pain status in those  
 who provided baseline information n = 2,718 n = 753 n = 2,293
 No foot pain 1939 (71.3) 366 (48.6) 2061 (89.9)
 Nondisabling foot pain 319 (11.7) 128 (17.0) 57 (2.5)
 Disabling foot pain 460 (16.9) 259 (34.4) 175 (7.6)
Table 2. Onset of Disabling Foot Pain at 3 Years in 2,258 Persons Who Did Not Have Disabling Foot Pain at Baseline: Stratified by the 
Presence (n = 319) or Absence (n = 1,939) of Nondisabling Foot Pain at Baseline
Onset of Disabling Foot Pain at 3 y, Frequencies (%)
Overall (n = 2,258)
No Foot Pain at  
Baseline (n = 1,939)
Nondisabling Foot Pain at  
Baseline (n = 319)
Overall 184 (8.1) 119 (6.1) 65 (20.4)
Gender
 Females 109 (9.4) 69 (7.1) 40 (21.5)
 Males 75 (6.8) 50 (5.2) 25 (18.8)
 Difference (95% confidence interval) 2.5% (0.3%–4.8%) 1.9% (−0.3%–4.0%) 2.7% (−6.5%–11.3%)
Age group at baseline
 Overall
  50–59 y 65 (6.7) 39 (4.7) 26 (17.7)
  60–69 y 68 (9.1) 47 (7.5) 21 (17.6)
  70+ y 51 (9.5) 33 (6.8) 18 (34.0)
  c2 (df) 4.34 (1) 3.11 (1) 4.44 (1)
  p .037 .078 .035
 Females
  50–59 y 43 (8.3) 28 (6.5) 15 (17.0)
  60–69 y 34 (9.1) 21 (6.9) 13 (18.8)
  70+ y 32 (11.7) 20 (8.2) 12 (41.4)
  c2 (df) 2.22 (1) 0.60 (1) 5.63 (1)
  p .137 .439 .018
 Males
  50–59 y 22 (4.8) 11 (2.8) 11 (18.6)
  60–69 y 34 (9.1) 26 (8.0) 8 (16.0)
  70+ y 19 (7.2) 13 (5.4) 6 (25.0)
  c2 (df) 2.37 (1) 3.44 (1) 0.22 (1)
  p .124 .064 .639
RODDY ET AL.478
long distances), and avoiding prolonged standing. The fre-
quency of onset increased with age, particularly among 
women generally and those women who had non-disabling 
foot pain at baseline rather than those without foot pain. The 
majority of persons with disabling foot pain at baseline con-
tinued to be affected 3 years later. The proportion of people 
reporting persistence at 3 years was higher in females than 
in males but did not appear to be influenced by age.
There are a number of implications of these findings. 
First, onset of disabling foot pain increases with increasing 
age. Hence, as the general population ages, the prevalence 
of disabling foot pain is likely to increase. Second, once 
disabling foot pain has developed, it is highly likely to per-
sist not only suggesting that prevention of disabling foot 
pain should be a priority but also raising the question of 
whether there is no effective treatment or whether effective 
treatment is, in general, not reaching people with the prob-
lem. However, 30%–40% of men and 20%–30% of women 
who reported disabling foot pain at baseline did not report it 
at 3 years, an observation that could reflect either successful 
treatment or a natural history of resolution or perhaps more 
likely, given evidence from other pain syndromes, that the 
natural history for some people is of intermittent episodes 
that come and go. Third, because the frequency of onset of 
disabling foot pain is greater in those who already have non
disabling foot pain, the latter might be useful as a marker of 
future disability and present a potential target for interven-
tions to prevent progression to disability.
Efforts for prevention could be targeted either at the onset 
of foot pain per se or at the secondary prevention of devel-
opment of physical disability by intervening early in those 
presenting with nondisabling foot pain. Early intervention 
would require early detection of nondisabling foot pain and 
wide recognition of its importance as a risk factor for dis-
abling foot pain. Future research should examine whether 
other physical, comorbid, social, or environmental factors 
predict the onset of disabling foot pain. Because onset is 
higher in older age groups, such risk factors may either be 
specific to or have a greater effect in older age groups. In 
this way, suitable targets for intervention at the level of both 
public health and individual patient care may be identified 
to prevent the onset of disabling foot pain in later life.
The implications and significance of these findings de-
pend clearly on the relevance of our measure of disabling 
foot pain. Several approaches to using the MFPDI to define 
disabling foot pain have been previously proposed. The 
original description of the MFPDI excluded the work and 
leisure items and identified a three-factor structure: pain (5 
items), function (10 items), and appearance (2 items) (15). 
Subsequent exploratory factor analyses by Menz and col-
leagues (18) and Cook and colleagues (19) have proposed 
different factor structures for these items (18,19). Recently, 
confirmatory factor analysis has found the three-factor solu-
tion put forward by Garrow and colleagues (15) to have the 
better fit (16).
Previous studies have defined disabling foot pain as the 
occurrence of a problem on at least 1 of the 17 MFPDI items 
(excluding the 2 items relating to work/leisure) on at least 
some days in the last month (6,18,19). However, this ap-
proach does not appear to distinguish between disabling and 
nondisabling foot pain in older adults (16). Hence in this 
study, we defined disabling foot pain as the occurrence of a 
problem on at least 1 of 10 items contained within Garrow’s 
Table 3. Frequency With Which Each MFPDI Function Item Was 
Reported as Occurring on Most/Every Day(s) at 3-Year Follow-Up 
in Those Experiencing Onset of Disabling Foot Pain
MFPDI Function  
Construct Items*
Onset at 3 y in Those Free of  
Disabling Foot Pain at  
Baseline (n = 184)
I avoid walking outside at all 14 (2.4)
I avoid walking long distances 88 (14.8)
I don’t walk in a normal way 70 (11.9)
I walk slowly 102 (17.2)
I have to stop and rest my feet 40 (6.7)
I avoid hard or rough surfaces when possible 97 (16.3)
I avoid standing for a long time 71 (11.9)
I catch the bus or use the car more often 139 (23.3)
I need help with housework/shopping 30 (5.1)
I get irritable when my feet hurt 23 (3.9)
Notes: MFPDI = Manchester Foot Pain and Disability Index.
* Each item is introduced with the prefix “Because of pain in my feet.”
Table 4. Persistence of Any Foot Pain and Disabling Foot Pain Over 
3 Years
Foot Pain  
Persistence  
(n = 779), 
Frequency (%)
Disabling Foot Pain  
Persistence (n = 460), 
Frequency (%)
Overall 576 (73.9) 330 (71.7)
Gender
 Females 364 (76.5) 218 (75.2)
 Males 212 (70.0) 112 (65.9)
 Difference  
  (95% confidence  
  interval)
6.5% (0.2%–13.0%) 9.3% (0.8%–18.0%)
Age group at baseline
 Overall
  50–59 y 204 (70.8) 100 (70.9)
  60–69 y 211 (75.9) 116 (73.0)
  70+ y 161 (75.6) 114 (71.3)
  c2 (df) 1.63 (1) 0.00 (1)
  p .202 .962
 Females
  50–59 y 130 (72.2) 67 (72.8)
  60–69 y 130 (79.3) 76 (80.0)
  70+ y 104 (78.8) 75 (72.8)
  c2 (df) 2.07 (1) 0.00 (1)
  p .150 .964
 Males
  50–59 y 74 (68.5) 33 (67.3)
  60–69 y 81 (71.1) 40 (62.5)
  70+ y 57 (70.4) 39 (68.4)
  c2 (df) 0.09 (1) 0.02 (1)
  p .763 .881
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function construct (15) on most/every day(s) in the last 
month, which we have previously shown to be valid and 
reliable (16).
The importance of foot pain is not simply its relevance as 
an isolated health problem but its potential to interfere sub-
stantially with mobility and quality of life, particularly in 
older people. Several previous studies have highlighted 
the contribution made by foot pain to locomotor disability 
(1,3–11) and estimated the population prevalence of foot 
pain associated with physical disability (4,6,20). To our 
knowledge, there have been no previous prospective studies 
describing the onset or persistence of disabling foot pain. 
However, our findings are comparable to estimates of the 
onset and persistence of musculoskeletal pain at other sites 
(21–27).
Limitations of our study warrant further discussion. A de-
gree of attrition over 3 years is inevitable in a study of this 
design. Age and gender differences between responders and 
nonresponders at 3 years have been reported previously 
(17). In this analysis, responders at 3 years were younger 
and had more frequently reported disabling foot pain at 
baseline than persons lost to follow-up. The onset of dis-
abling foot pain at 3 years could therefore have been over
estimated if response at 3 years among persons free of foot 
pain and disability at baseline was selectively higher in 
those experiencing onset of disabling foot pain than in those 
lost to follow-up. A separate point is that our definition of 
disabling foot pain at both baseline and 3-year follow-up 
was based only on a report of foot pain in the previous 12 
months and completion of the MFPDI with reference to the 
previous month, and so, fluctuations in either pain or dis-
ability between baseline and 3-year follow-up would not be 
captured.
In summary, the frequency of onset of disabling foot pain 
increases with age, particularly among women, suggesting 
that the prevalence of disabling foot pain will increase as 
the population ages. Nondisabling foot pain appears to be 
an important risk factor for the development of disabling 
pain and presents a potential target for intervention to pre-
vent the onset of this significant health problem, which, 
once established, is likely to persist. Further research is re-
quired to identify other predictors of disabling foot pain and 
identify targets for intervention and prevention.
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